Ton A. Roeleveld
YOU?
Author Swipe
View article: Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging–directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study
Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging–directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study Open
In a community-based diagnostic setting (24% GG ≥2 disease), applying a post-MRI PSA density threshold of ≥0.20 rather than the recommended threshold of 0.10 ng/ml2 in men with PI-RADS 3 lesions reduces unnecessary biopsies while maintaini…
View article: Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York–Mason technique
Management in robot-assisted radical prostatectomy patients with recto-urethral fistulas: the York–Mason technique Open
Purpose To present the outcomes of the York–Mason procedure for managing recto-urethral fistula (RUF) after robot-assisted radical prostatectomy (RARP). Methods A single-center retrospective cohort study was conducted at the Antoni van Lee…
View article: Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1
Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1 Open
Background: The co-treatment of androgen deprivation therapy (ADT) for advanced prostate cancer (PCa) with the fetal estrogen estetrol (E4) may further inhibit endocrine PCa tumor stimulators. We previously reported the suppression of foll…
View article: Feasibility of Image-guided Navigation with Electromagnetic Tracking During Robot-assisted Sentinel Node Biopsy: A Prospective Study
Feasibility of Image-guided Navigation with Electromagnetic Tracking During Robot-assisted Sentinel Node Biopsy: A Prospective Study Open
We carried out a study on the feasibility of imaging-guided navigation in robot-assisted prostate surgery. Our results show that this technique is feasible, safe, and effective.
View article: The Anti-Tumor Effects of the Fetal Estrogen Estetrol in Advanced Prostate Cancer
The Anti-Tumor Effects of the Fetal Estrogen Estetrol in Advanced Prostate Cancer Open
Background: Co-treatment of the fetal estrogen estetrol (E4) with androgen deprivation therapy (ADT) for advanced prostate cancer (PCa) may further inhibit endocrine PCa tumor stimulators including testosterone (T), prostate-specific antig…
View article: A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
A Comparison of Globally Applied Prognostic Risk Groups and the Prevalence of Metastatic Disease on Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer Open
The use of various risk classification systems in patients with prostate cancer helps identify those at a higher risk of having metastatic disease on prostate-specific membrane antigen positron emission tomography/computed tomography for p…
View article: A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging–directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men
A Prospective Multicenter Comparison Study of Risk-adapted Ultrasound-directed and Magnetic Resonance Imaging–directed Diagnostic Pathways for Suspected Prostate Cancer in Biopsy-naïve Men Open
Among men with suspected prostate cancer, relevant cancers were equally well detected by risk-based pathways using either ultrasound or magnetic resonance imaging (MRI) to guide biopsy of the prostate. If prostate MRI availability is suffi…
View article: Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi)
Estetrol Cotreatment of Androgen Deprivation Therapy in Infiltrating or Metastatic, Castration-sensitive Prostate Cancer: A Randomized, Double-blind, Phase II Trial (PCombi) Open
Cotreatment of androgen deprivation therapy with high-dose estetrol in advanced prostate cancer patients results in fewer occurrences of hot flushes, bone protection, and other antitumor benefits. Nipple sensitivity and gynecomastia may oc…
View article: Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -
Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial - Open
Purpose The detection of lymph-node metastases (N1) with conventional imaging such as magnetic resonance imaging (MRI) and computed tomography (CT) is inadequate for primarily diagnosed prostate cancer (PCa). Prostate-specific membrane ant…
View article: MP62-16 A PROSPECTIVE EVALUATION OF PELVIC LYMPH NODE STAGING WITH <sup>18</sup> FLUORINE PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET/CT PRIOR TO EXTENDED LYMPH NODE DISSECTION IN PRIMARY PROSTATE CANCER. THE SALT STUDY
MP62-16 A PROSPECTIVE EVALUATION OF PELVIC LYMPH NODE STAGING WITH <sup>18</sup> FLUORINE PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET/CT PRIOR TO EXTENDED LYMPH NODE DISSECTION IN PRIMARY PROSTATE CANCER. THE SALT STUDY Open
You have accessJournal of UrologyProstate Cancer: Staging I (MP62)1 Apr 2020MP62-16 A PROSPECTIVE EVALUATION OF PELVIC LYMPH NODE STAGING WITH 18FLUORINE PROSTATE-SPECIFIC MEMBRANE ANTIGEN PET/CT PRIOR TO EXTENDED LYMPH NODE DISSECTION IN …